Sensitive high-performance liquid chromatography/mass spectrometry method for determination of steviol in rat plasma

by Wang, L.Z., Goh, B.C., Fan, L., Lee, H.S.
Published 2012

Sensitive high-performance liquid chromatography/mass spectrometry method for determination of steviol in rat plasma

by Wang, L.Z., Goh, B.C., Fan, L., Lee, H.S.
Published 2014

Effect of some enhancers on the permeation of haloperidol through rat skin in vitro

by Vaddi, H.K., Wang, L.Z., Ho, P.C., Chan, S.Y.
Published 2014

Resisting resistance to cancer immunotherapy

by RAGHAV SUNDAR, Lam, W.S.-T., Wang, L.Z., Roudi, R., Yong, W.-P., Syn, N.L.
Published 2021

Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectives

by Ong, P.S, Wang, L.Z, Dai, X, Tseng, S.H, Loo, S.J, Sethi, G
Published 2020

Effect of cetrimide and ascorbic acid on in vitro human skin permeation of haloperidol

by Vaddi, H.K., Wang, L.Z., Ho, P.C.-L., Chan, Y.W., Chan, S.Y.
Published 2014

Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay

by Wang, L.Z., Ho, P.C., Lee, H.S., Vaddi, H.K., Chan, Y.W., Yung, C.S.
Published 2014

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma

by Wang, L.Z., Goh, B.C., Grigg, M.E., Lee, S.C., Khoo, Y.M., Lee, H.S.
Published 2014

Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356

by Shanmugam, MK, Arfuso, F, Arumugam, S, Chinnathambi, A, Bian, J, Warrier, S, Wang, LZ, Kumar, AP, Ahn, KS, Sethi, G, Lakshmanan, M
Published 2022

Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications

by Ma, C.Y., Zhang, C.P., Zhong, L.P., Pan, H.Y., Chen, W.T., Wang, L.Z., Andrew, O.W., Ji, T., Han, W.
Published 2013

Role of novel histone modifications in cancer

by Shanmugam, M.K, Arfuso, F, Arumugam, S, Chinnathambi, A, Jinsong, B, Warrier, S, Wang, L.Z, Kumar, A.P, Ahn, K.S, Sethi, G, Lakshmanan, M
Published 2020

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: A Cancer Therapeutics Research Group study

by Soo, R.A., Lim, H.L., Wang, L.Z., Lee, H.S., Millward, M.J., Tok, L.T., Lee, S.C., Lehnert, M., Goh, B.C.
Published 2014

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic eva...

by Ma, B., Goh, B.C., Tan, E.H., Lam, K.C., Soo, R., Leong, S.S., Wang, L.Z., Mo, F., Chan, A.T.C., Zee, B., Mok, T.
Published 2014

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic eva...

by Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S.
Published 2011

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell l...

by Soo, R.A., Wang, L.Z., Tham, L.S., Yong, W.P., Boyer, M., Lim, H.L., Lee, H.S., Millward, M., Liang, S., Beale, P., Lee, S.C., Goh, B.C.
Published 2014

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

by Wong, A.L., Seng, K.Y., Ong, E.M., Wang, L.Z., Oscar, H., Cordero, M.T., Copones, R., Fan, L., Tan, S.H., Goh, B.C., Lee, S.C.
Published 2014

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell l...

by Soo, R.A., Wang, L.Z., Tham, L.S., Yong, W.P., Lim, H.L., Lee, S.C., Goh, B.C., Lee, H.S, Boyer, M., Millward, M., Beale, P., Liang, S.
Published 2011

PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients

by Hor, S.Y., Lee, S.C., Wong, C.I., Lim, Y.W., Lim, R.C., Wang, L.Z., Fan, L., Guo, J.Y., Lee, H.S., Goh, B.C., Tan, T.
Published 2014

PXR, CAR and HNF4α genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients

by Hor, S.Y., Tan, T., Lee, S.C., Wong, C.I., Lim, Y.W., Lim, R.C., Wang, L.Z., Guo, J.Y., Goh, B.C., Fan, L., Lee, H.S.
Published 2011

Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients

by Soo, R.A., Wang, L.Z., Yong, W.P., Lee, S.C., Tham, L.S., Goh, B.C., Ng, S.S., Chong, P.Y., Soong, R., Liu, J.J., Lee, H.S., Choo, T.B.
Published 2011